We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.3M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$78.9M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$77.4M
4
AAPL icon
Apple
AAPL
+$77M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$70.1M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAN icon
2976
Banco Santander
SAN
$209B
$114K ﹤0.01%
+31,510
New +$116K
CARM
2977
DELISTED
Carisma Therapeutics
CARM
$113K ﹤0.01%
7,122
+695
+11% +$33.4K
GTBP icon
2978
GT Biopharma
GTBP
$11.8M
$112K ﹤0.01%
556
-65
-10% -$19.6K
ACIC icon
2979
American Coastal Insurance
ACIC
$494M
$110K ﹤0.01%
30,366
-34,727
-53% -$139K
OTLK icon
2980
Outlook Therapeutics
OTLK
$184M
$108K ﹤0.01%
2,500
+201
+9% +$9.7K
REV
2981
DELISTED
Revlon, Inc.
REV
$108K ﹤0.01%
10,662
+40
+0.4% +$451
ELTX icon
2982
Elicio Therapeutics
ELTX
$82.7M
$107K ﹤0.01%
+1,095
New +$118K
CLNN icon
2983
Clene
CLNN
$68.4M
$106K ﹤0.01%
778
+26
+3% +$4.44K
MUFG icon
2984
Mitsubishi UFJ Financial
MUFG
$253B
$106K ﹤0.01%
+17,940
New +$99.6K
PSEC icon
2985
Prospect Capital
PSEC
$1.17B
$104K ﹤0.01%
13,541
+15
+0.1% +$121
SRT
2986
DELISTED
Startek Inc.
SRT
$104K ﹤0.01%
18,844
-477
-2% -$2.94K
AVTX icon
2987
Avalo Therapeutics
AVTX
$970M
$103K ﹤0.01%
16
– –
BMTX
2988
DELISTED
BM Technologies, Inc.
BMTX
$103K ﹤0.01%
11,539
-1,728
-13% -$17.7K
ADN
2989
DELISTED
Advent Technologies
ADN
$99K ﹤0.01%
379
+2
+0.5% +$486
PAYO icon
2990
Payoneer
PAYO
$2.41B
$99K ﹤0.01%
+11,624
New +$113K
FFAI
2991
Faraday Future Intelligent Electric
FFAI
$10.6M
– –
0
– –
AFIB
2992
DELISTED
Acutus Medical Inc
AFIB
$98K ﹤0.01%
11,090
+725
+7% +$9.54K
TH icon
2993
Target Hospitality
TH
$1.65B
$95K ﹤0.01%
25,357
-827
-3% -$3.04K
HYRE
2994
DELISTED
HyreCar Inc. Common Stock
HYRE
$95K ﹤0.01%
11,154
+825
+8% +$11.3K
SHCR
2995
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$93K ﹤0.01%
+11,337
New +$85.7K
INNV icon
2996
InnovAge Holding
INNV
$1.51B
$91K ﹤0.01%
13,751
+909
+7% +$14.1K
LYG icon
2997
Lloyds Banking Group
LYG
$91B
$88K ﹤0.01%
+35,796
New +$87.7K
HOOK
2998
DELISTED
HOOKIPA Pharma
HOOK
$87K ﹤0.01%
1,484
+145
+11% +$10.5K
RTB
2999
RTB Digital
RTB
$227M
$86K ﹤0.01%
+30
New +$101K
SMFG icon
3000
Sumitomo Mitsui Financial
SMFG
$163B
$84K ﹤0.01%
+11,920
New +$83K
118 119
120
121 122

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.